Palisade Bio closes $138 million public offering to fund drug trial Oct 2, 2025 04:05PM
Palisade Bio Announces Closing of Upsized $138 Million Public Offering of Common Stock and Including Full Exercise of Over-Allotment Option Oct 2, 2025 04:05PM
Palisade Bio prices $120 million stock offering at $0.70 per share Oct 1, 2025 09:20AM
Palisade Bio Announces Pricing of Upsized $120 Million Underwritten Public Offering of Common Stock Oct 1, 2025 09:20AM
Palisade Bio Announces Exercise of Previously Issued Warrants for $3.9 Million Jul 23, 2025 08:00PM


Dec 13, 2024 04:05PM Palisade Bio Announces Closing of $5 Million Underwritten Public Offering Priced At-Market Under Nasdaq Rules
Dec 12, 2024 12:08PM Palisade Bio (PALI) Announces Pricing of $5 Million Underwritten Public Offering Priced At-Market Under Nasdaq Rules
Dec 12, 2024 12:05PM Palisade Bio Announces Pricing of $5 Million Underwritten Public Offering Priced At-Market Under Nasdaq Rules
May 29, 2024 06:47AM Ladenburg Thalmann Reiterates Buy Rating on Palisade Bio Inc. (PALI)
May 7, 2024 07:30AM Palisade Bio Announces Closing of $4 Million Private Placement Priced At-The- Market Under Nasdaq Rules
May 2, 2024 08:33AM Palisade Bio Inc. (PALI) Announces $4 Million Private Placement of Common Stock, Warrants
May 2, 2024 08:30AM Palisade Bio Announces $4 Million Private Placement Priced At-The- Market Under Nasdaq Rules
Feb 1, 2024 06:19AM Palisade Bio Inc. (PALI) Enters Warrant Inducement Agreements
Jan 30, 2024 09:26AM Palisade Bio Inc. (PALI) Announces Exercise for $2.5M
Jan 30, 2024 09:25AM Palisade Bio Announces Exercise of Previously Issued Warrants for $2.5 Million
Sep 11, 2023 04:01PM Palisade Bio Announces Closing of $2 Million Registered Direct Offering Priced At Market Under Nasdaq Rules
Sep 7, 2023 08:30AM Palisade Bio Inc. (PALI) Announces $2M Share Offering
Sep 7, 2023 08:30AM Palisade Bio Announces $2 Million Registered Direct Offering of Common Stock Priced At Market Under Nasdaq Rules
Apr 3, 2023 08:31AM Palisade Bio Inc. (PALI) sells 2.27 million shares at $2.64 in direct offering
Apr 3, 2023 08:30AM Palisade Bio Announces $6 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under Nasdaq Rules
Jan 31, 2023 01:58PM Ladenburg on Palisade Bio Inc. (PALI): 'We are growing more confident in the regulatory path LB1148'
Jan 4, 2023 05:15PM Palisade Bio Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under Nasdaq Rules
Dec 30, 2022 08:46AM Palisade Bio Inc. (PALI) Announces $2.5 Million Registered Direct Offering and Concurrent Private Placement of Common Stock, Warrants
Dec 30, 2022 08:45AM Palisade Bio Announces $2.5 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under Nasdaq Rules
Sep 21, 2022 09:23AM Palisade Bio to Present at the Ladenburg Thalmann 2022 Healthcare Conference
Aug 16, 2022 04:05PM Palisade Bio Announces Closing of $13.8 Million Upsized Underwritten Public Offering and Full Exercise of Over-Allotment Option
Aug 12, 2022 08:31AM Palisade Bio Inc. (PALI) Prices $12 Million Upsized Underwritten Public Offering of Common Stock, Warrants
Aug 12, 2022 08:30AM Palisade Bio Announces Pricing of $12 Million Upsized Underwritten Public Offering
May 6, 2022 08:30AM Palisade Bio Inc. (PALI) Announces 3.65M Share Direct Offering at $0.55/sh
May 6, 2022 08:30AM Palisade Bio Announces $2.0 Million Registered Direct Offering